Comment on 'Lanthanum deposition in a dialysis patient'.

Suppr

超能文献

作者信息

D'Haese Patrick, Damment Stephen J P

出版信息

Nephrol Dial Transplant. 2010 Jan;25(1):314; author reply 314-6. doi: 10.1093/ndt/gfp531. Epub 2009 Nov 11.

DOI:10.1093/ndt/gfp531

PMID:19906657

Abstract

摘要

相似文献

Comment on 'Lanthanum deposition in a dialysis patient'.

Nephrol Dial Transplant. 2010 Jan;25(1):314; author reply 314-6. doi: 10.1093/ndt/gfp531. Epub 2009 Nov 11.

Lanthanum deposition in a dialysis patient.

Nephrol Dial Transplant. 2009 Oct;24(10):3247-50. doi: 10.1093/ndt/gfp364. Epub 2009 Jul 22.

Where have all the lanthanum salts gone, long time passing?

Kidney Int. 2003 Dec;64(6):2327-8; author reply 2328. doi: 10.1046/j.1523-1755.2003.341_8.x.

Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up.

Nephrol Dial Transplant. 2006 Aug;21(8):2217-24. doi: 10.1093/ndt/gfl146. Epub 2006 Apr 4.

Lanthanum carbonate (Shire).

IDrugs. 2003 Jul;6(7):688-95.

Lanthanum carbonate (Fosrenol): a novel agent for the treatment of hyperphosphataemia in renal failure and dialysis patients.

Int J Clin Pract. 2005 Sep;59(9):1091-6. doi: 10.1111/j.1368-5031.2005.00592.x.

[Pharmacodynamic and pharmacokinetic profile of lanthanum carbonate].

Clin Calcium. 2009 Feb;19(2):213-8.

Lanthanum: new drug. Hyperphosphataemia in dialysis patients: more potential problems than benefits.

Prescrire Int. 2007 Apr;16(88):47-50.

A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients.

Kidney Int Suppl. 2003 Jun(85):S73-8. doi: 10.1046/j.1523-1755.63.s85.18.x.

Boning up on lanthanum.

Semin Dial. 2006 Jan-Feb;19(1):87-9. doi: 10.1111/j.1525-139X.2006.00127a.x.

引用本文的文献

Pathophysiology and therapies of CKD-associated secondary hyperparathyroidism.

Clin Kidney J. 2025 Mar 13;18(Suppl 1):i15-i26. doi: 10.1093/ckj/sfae423. eCollection 2025 Mar.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Comment on 'Lanthanum deposition in a dialysis patient'.

Nephrol Dial Transplant. 2010 Jan;25(1):314; author reply 314-6. doi: 10.1093/ndt/gfp531. Epub 2009 Nov 11.

Lanthanum deposition in a dialysis patient.

Nephrol Dial Transplant. 2009 Oct;24(10):3247-50. doi: 10.1093/ndt/gfp364. Epub 2009 Jul 22.

Where have all the lanthanum salts gone, long time passing?

Kidney Int. 2003 Dec;64(6):2327-8; author reply 2328. doi: 10.1046/j.1523-1755.2003.341_8.x.

Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up.

Nephrol Dial Transplant. 2006 Aug;21(8):2217-24. doi: 10.1093/ndt/gfl146. Epub 2006 Apr 4.

Lanthanum carbonate (Shire).

IDrugs. 2003 Jul;6(7):688-95.

Lanthanum carbonate (Fosrenol): a novel agent for the treatment of hyperphosphataemia in renal failure and dialysis patients.

Int J Clin Pract. 2005 Sep;59(9):1091-6. doi: 10.1111/j.1368-5031.2005.00592.x.

[Pharmacodynamic and pharmacokinetic profile of lanthanum carbonate].

Clin Calcium. 2009 Feb;19(2):213-8.

Lanthanum: new drug. Hyperphosphataemia in dialysis patients: more potential problems than benefits.

Prescrire Int. 2007 Apr;16(88):47-50.

A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients.

Kidney Int Suppl. 2003 Jun(85):S73-8. doi: 10.1046/j.1523-1755.63.s85.18.x.

Boning up on lanthanum.

Semin Dial. 2006 Jan-Feb;19(1):87-9. doi: 10.1111/j.1525-139X.2006.00127a.x.

引用本文的文献

Pathophysiology and therapies of CKD-associated secondary hyperparathyroidism.

Clin Kidney J. 2025 Mar 13;18(Suppl 1):i15-i26. doi: 10.1093/ckj/sfae423. eCollection 2025 Mar.